Cas no 866620-21-5 (5-Tert-butylpyridin-2-amine)

5-Tert-butylpyridin-2-amine structure
5-Tert-butylpyridin-2-amine structure
Product Name:5-Tert-butylpyridin-2-amine
CAS No:866620-21-5
MF:C9H14N2
MW:150.220861911774
MDL:MFCD12033220
CID:2102111
PubChem ID:20587962
Update Time:2024-10-26

5-Tert-butylpyridin-2-amine Chemical and Physical Properties

Names and Identifiers

    • 5-(1,1-dimethylethyl)-2-Pyridinamine
    • 5-tert-butylpyridin-2-amine
    • 5-(tert-butyl)pyridin-2-amine
    • 2-amino-5-(tert-butyl)pyridine
    • 2-Pyridinamine, 5-(1,1-dimethylethyl)-
    • 5-tert-butylpyridin-2-ylamine
    • MKEUSJZGHJDRHG-UHFFFAOYSA-N
    • 5-tert-Butyl-pyridin-2-ylamine
    • 5-(1,1-Dimethylethyl)-2-pyridinamine (ACI)
    • 5-tert-Butyl-2-pyridineamine
    • PB43618
    • AS-78036
    • D95143
    • SY199531
    • DB-358517
    • EN300-202769
    • MFCD12033220
    • CHEMBL1800271
    • SCHEMBL284446
    • CS-0187955
    • 866620-21-5
    • AKOS015945283
    • 5-Tert-butylpyridin-2-amine
    • MDL: MFCD12033220
    • Inchi: 1S/C9H14N2/c1-9(2,3)7-4-5-8(10)11-6-7/h4-6H,1-3H3,(H2,10,11)
    • InChI Key: MKEUSJZGHJDRHG-UHFFFAOYSA-N
    • SMILES: N1C(=CC=C(C=1)C(C)(C)C)N

Computed Properties

  • Exact Mass: 150.115698455g/mol
  • Monoisotopic Mass: 150.115698455g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 1
  • Complexity: 126
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.3
  • Topological Polar Surface Area: 38.9

5-Tert-butylpyridin-2-amine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM328698-5g
5-tert-butylpyridin-2-amine
866620-21-5 95%+
5g
$7239 2021-08-18
TRC
B490763-2.5mg
5-tert-butylpyridin-2-amine
866620-21-5
2.5mg
$ 50.00 2022-06-07
TRC
B490763-5mg
5-tert-butylpyridin-2-amine
866620-21-5
5mg
$ 70.00 2022-06-07
TRC
B490763-25mg
5-tert-butylpyridin-2-amine
866620-21-5
25mg
$ 295.00 2022-06-07
Alichem
A029182336-1g
5-(tert-Butyl)pyridin-2-amine
866620-21-5 95%
1g
$1361.22 2023-08-31
Alichem
A029182336-5g
5-(tert-Butyl)pyridin-2-amine
866620-21-5 95%
5g
$3520.44 2023-08-31
eNovation Chemicals LLC
D634599-500mg
2-Pyridinamine, 5-(1,1-dimethylethyl)-
866620-21-5 95%
500mg
$595 2024-08-03
eNovation Chemicals LLC
D634599-1g
2-Pyridinamine, 5-(1,1-dimethylethyl)-
866620-21-5 95%
1g
$655 2024-08-03
eNovation Chemicals LLC
Y1006187-100mg
5-tert-butylpyridin-2-amine
866620-21-5 97%
100mg
$255 2024-05-23
eNovation Chemicals LLC
Y1006187-250MG
5-tert-butylpyridin-2-amine
866620-21-5 97%
250mg
$395 2024-05-23

5-Tert-butylpyridin-2-amine Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Trifluoroacetic acid ;  5 h, rt
Reference
Synthesis of useful fragments in drug discovery: 2-Amino-5-tert-butylpyridine and its oxidized analogs
Thomson, Christopher G.; et al, Bioorganic & Medicinal Chemistry Letters, 2011, 21(14), 4281-4283

Production Method 2

Reaction Conditions
1.1 Reagents: Potassium hydroxide ,  Hydrazine hydrate (1:1) Solvents: Diethylene glycol ;  72 h, reflux
2.1 Reagents: Trifluoroacetic acid ;  5 h, rt
Reference
Synthesis of useful fragments in drug discovery: 2-Amino-5-tert-butylpyridine and its oxidized analogs
Thomson, Christopher G.; et al, Bioorganic & Medicinal Chemistry Letters, 2011, 21(14), 4281-4283

Production Method 3

Reaction Conditions
1.1 Reagents: Cuprous cyanide Solvents: Tetrahydrofuran ;  -78 °C; 30 min, -78 °C
1.2 Solvents: Tetrahydrofuran ;  1 h, -78 °C; 16 h, rt
2.1 Reagents: Trifluoroacetic acid Solvents: Dichloromethane ;  0 °C; 0 °C → rt; 2 h, rt
2.2 Reagents: Sodium bicarbonate Solvents: Water ;  neutralized, rt
Reference
Synthesis and evaluation of various heteroaromatic benzamides as analogues of -ylidene-benzamide cannabinoid type 2 receptor agonists
Moir, Michael; et al, Tetrahedron Letters, 2019, 60(36),

Production Method 4

Reaction Conditions
1.1 Reagents: Cyclohexanamine, N-cyclohexyl-, lithium salt (1:1) Catalysts: Tri-tert-butylphosphine ,  Bis(dibenzylideneacetone)palladium Solvents: Toluene ;  overnight, rt
2.1 Reagents: Lithium borohydride Solvents: Tetrahydrofuran ;  2 d, rt
3.1 Reagents: Dess-Martin periodinane Solvents: Dichloromethane ;  10 min, rt
4.1 Reagents: Potassium hydroxide ,  Hydrazine hydrate (1:1) Solvents: Diethylene glycol ;  72 h, reflux
5.1 Reagents: Trifluoroacetic acid ;  5 h, rt
Reference
Synthesis of useful fragments in drug discovery: 2-Amino-5-tert-butylpyridine and its oxidized analogs
Thomson, Christopher G.; et al, Bioorganic & Medicinal Chemistry Letters, 2011, 21(14), 4281-4283

Production Method 5

Reaction Conditions
1.1 Reagents: Trifluoroacetic acid Solvents: Dichloromethane ;  0 °C; 0 °C → rt; 2 h, rt
1.2 Reagents: Sodium bicarbonate Solvents: Water ;  neutralized, rt
Reference
Synthesis and evaluation of various heteroaromatic benzamides as analogues of -ylidene-benzamide cannabinoid type 2 receptor agonists
Moir, Michael; et al, Tetrahedron Letters, 2019, 60(36),

Production Method 6

Reaction Conditions
1.1 Reagents: Dess-Martin periodinane Solvents: Dichloromethane ;  10 min, rt
2.1 Reagents: Potassium hydroxide ,  Hydrazine hydrate (1:1) Solvents: Diethylene glycol ;  72 h, reflux
3.1 Reagents: Trifluoroacetic acid ;  5 h, rt
Reference
Synthesis of useful fragments in drug discovery: 2-Amino-5-tert-butylpyridine and its oxidized analogs
Thomson, Christopher G.; et al, Bioorganic & Medicinal Chemistry Letters, 2011, 21(14), 4281-4283

Production Method 7

Reaction Conditions
1.1 Reagents: Magnesium Solvents: Tetrahydrofuran
2.1 Reagents: Cuprous cyanide Solvents: Tetrahydrofuran ;  -78 °C; 30 min, -78 °C
2.2 Solvents: Tetrahydrofuran ;  1 h, -78 °C; 16 h, rt
3.1 Reagents: Trifluoroacetic acid Solvents: Dichloromethane ;  0 °C; 0 °C → rt; 2 h, rt
3.2 Reagents: Sodium bicarbonate Solvents: Water ;  neutralized, rt
Reference
Synthesis and evaluation of various heteroaromatic benzamides as analogues of -ylidene-benzamide cannabinoid type 2 receptor agonists
Moir, Michael; et al, Tetrahedron Letters, 2019, 60(36),

Production Method 8

Reaction Conditions
1.1 Reagents: Lithium borohydride Solvents: Tetrahydrofuran ;  2 d, rt
2.1 Reagents: Dess-Martin periodinane Solvents: Dichloromethane ;  10 min, rt
3.1 Reagents: Potassium hydroxide ,  Hydrazine hydrate (1:1) Solvents: Diethylene glycol ;  72 h, reflux
4.1 Reagents: Trifluoroacetic acid ;  5 h, rt
Reference
Synthesis of useful fragments in drug discovery: 2-Amino-5-tert-butylpyridine and its oxidized analogs
Thomson, Christopher G.; et al, Bioorganic & Medicinal Chemistry Letters, 2011, 21(14), 4281-4283

Production Method 9

Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Dimethylacetamide ;  1 h, 0 °C
2.1 Reagents: Cyclohexanamine, N-cyclohexyl-, lithium salt (1:1) Catalysts: Tri-tert-butylphosphine ,  Bis(dibenzylideneacetone)palladium Solvents: Toluene ;  overnight, rt
3.1 Reagents: Lithium borohydride Solvents: Tetrahydrofuran ;  2 d, rt
4.1 Reagents: Dess-Martin periodinane Solvents: Dichloromethane ;  10 min, rt
5.1 Reagents: Potassium hydroxide ,  Hydrazine hydrate (1:1) Solvents: Diethylene glycol ;  72 h, reflux
6.1 Reagents: Trifluoroacetic acid ;  5 h, rt
Reference
Synthesis of useful fragments in drug discovery: 2-Amino-5-tert-butylpyridine and its oxidized analogs
Thomson, Christopher G.; et al, Bioorganic & Medicinal Chemistry Letters, 2011, 21(14), 4281-4283

5-Tert-butylpyridin-2-amine Raw materials

5-Tert-butylpyridin-2-amine Preparation Products

5-Tert-butylpyridin-2-amine Related Literature

Recommended suppliers
Nanjing jingzhu bio-technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing jingzhu bio-technology Co., Ltd.
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.